drugset / Trial / NCT00620568
Study Evaluating Multiple Ascending Dose in Schizophrenia Patients
Phase 1
Terminated
32 enrolled
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
This is a randomized, inpatient, ascending multiple dose study to assess safety and tolerability of SLV-313 SR tablets administered orally to subjects with schizophrenia and schizoaffective disorder.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADOPRAZINE | Small molecule | — | Oral |
Indications
No indication recorded.